Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
| Image |  |
|---|---|
| Description | scientific article published on 05 June 2020 |
| Author/s |
author: David A. Lipson Morrys C Kaisermann David M. G. Halpin MeiLan K Han Gerard J Criner Fernando J Martinez Sally Kilbride Mark T Dransfield Robert A. Wise |
| Publication date | June 5, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |